Clinical Trials Logo

HIV clinical trials

View clinical trials related to HIV.

Filter by:
  • No longer available  
  • Page 1

NCT ID: NCT02759042 No longer available - HIV Clinical Trials

An Expanded Access Protocol for a Single Subject Who Has Completed 24-Weeks of Treatment in PR0140_CD02 Study

CD02_EA
Start date: n/a
Phase: N/A
Study type: Expanded Access

The primary objective is to provide continued access to PRO 140 to a subject who has completed participation in PRO140_CD02.

NCT ID: NCT02069652 No longer available - HIV Clinical Trials

Prevention of Transmission of Sexually Transmitted Diseases in the Youth Through Effective Intervention,

Start date: July 2013
Phase: N/A
Study type: Expanded Access

The data of Taiwan CDC showed the total HIV victims amounted up to 22,020 from 1984 to 2011. Under risk factor analysis, it indicated the increasing victims among MSM (men having sex with men, including homosexuals & bisexuals) cohorts, from 64% of them in 2009 to 72% in 2011. For age stratification of patients, the youth (from 15 to 24 years old) comprised of 18.5% (4078). Among them, 40% are students. MSM are still the main population (over 80%) from 2009 to 2011. Therefore it is crucial to target the young MSM.

NCT ID: NCT00801515 No longer available - HIV Clinical Trials

A Compassionate Access Protocol For Those Patients Who Have Completed A4001029

Start date: August 2009
Phase: Phase 3
Study type: Expanded Access

This is a compassionate study to provide continued access to maraviroc for only those subjects completing study A4001029 who are showing clinical benefit. Assessments of safety and tolerability of maraviroc when added to OBT will be continued.